Monitoring renal safety in mineralocorticoid receptor antagonist trials
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.764
Abstract: Overall, patients with heart failure (HF) and preserved left ventricular ejection fraction (HFpEF) assigned to spironolactone in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)1 trial did not achieve a… read more here.
Keywords: patients enrolled; safety; heart failure; monitoring renal ... See more keywords
In vivo monitoring of renal tubule volume fraction using dynamic parametric MRI
Sign Up to like & getrecommendations! Published in 2024 at "Magnetic Resonance in Medicine"
DOI: 10.1002/mrm.30023
Abstract: The increasing incidence of kidney diseases is a global concern, and current biomarkers and treatments are inadequate. Changes in renal tubule luminal volume fraction (TVF) serve as a rapid biomarker for kidney disease and improve… read more here.
Keywords: vivo monitoring; renal tubule; volume fraction; monitoring renal ... See more keywords
Routine adherence monitoring after renal transplantation
Sign Up to like & getrecommendations! Published in 2019 at "Transplant International"
DOI: 10.1111/tri.13422
Abstract: Successful renal transplantation requires lifelong immunosuppression, usually with a combination of drugs, to prevent rejection and immunologically-mediated damage to the graft. To achieve maximum effect, these immunosuppressive agents must be taken regularly as prescribed. This… read more here.
Keywords: adherence monitoring; renal transplantation; monitoring renal; transplantation ... See more keywords
Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13101751
Abstract: Nephropathy is a major Fabry disease complication. Kidney biopsies reveal glomerulosclerosis even in pediatric patients. The main manifestations of Fabry nephropathy include reduced glomerular filtration rate and proteinuria. In 2016, an oral pharmacological Chaperone was… read more here.
Keywords: biomarkers monitoring; monitoring renal; damage; review ... See more keywords